Evaluation of nephrotoxicity and prognosis in patients treated with colistin due to hospital-acquired pneumonia


KORKMAZ EKREN P., Toreyin Z. N., Berk Takir H., Kalamanoglu Balci M., Gaygisiz U., GÜRSEL G., ...Daha Fazla

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, cilt.65, sa.4, ss.271-281, 2017 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 65 Sayı: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.5578/tt.59748
  • Dergi Adı: TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.271-281
  • Anahtar Kelimeler: Nosocomial infection, pneumonia, multidrug resistant, colistimethate sodium, toxicity, RESISTANT ACINETOBACTER-BAUMANNII, VENTILATOR-ASSOCIATED PNEUMONIA, ACUTE-RENAL-FAILURE, INTENSIVE-CARE-UNIT, INTRAVENOUS COLISTIN, PSEUDOMONAS-AERUGINOSA, COLISTIMETHATE SODIUM, INFECTIONS, EFFICACY, THERAPY
  • Marmara Üniversitesi Adresli: Evet

Özet

Introduction: Colistimethate sodium (CMS) is frequently used in the treatment of nosocomial multidrug-resistant gram-negative infections. Nephrotoxicity is the most important side effect. The aim of this study is to evaluate the effect of colistin on nephrotoxicity and to assess prognosis in patients treated with CMS due to hospital-acquired pneumonia (HAP).